Company Profile

AcuraStem is a patient-based biotechnology company that is revolutionizing the way treatments are developed for neurodegenerative diseases.

AcuraStem

Headquarters

Monrovia, California, USA

Founded Year

2016

Company Status

Private

Website

AcuraStem

Operating Status

Active

Social Media

Founders

Sam Alworth
Co-Founder

Justin Ichida
Co-Founder

Paul August
Co-Founder

Qing Liu-Michael
Co-Founder

About

AcuraStem is a patient-based biotechnology company that is revolutionizing the way treatments are developed for neurodegenerative diseases. Based in Monrovia, California, AcuraStem is at the forefront of drug discovery, using their proprietary iNeuroRx® technology platform to develop novel and effective treatments.

The company’s groundbreaking approach involves creating individual patient models that accurately recapitulate neurodegenerative disease processes. This patient-based approach leads to more effective treatments that can work broadly for patients, not limited to rare, genetically defined subtypes.

AcuraStem’s therapeutic pipeline is robust and diverse. They have utilized their technology to advance highly promising therapeutic candidates for the treatment of ALS and FTD. They are confident these treatments will be effective for diverse forms of disease, not limited to rare, genetically defined subsets.

Trending Companies

About Us

futureTEKnow is a global database of emerging technology companies. Discover the latest disruptors and innovators in the field.

 

#AI
#ImmersiveTech
#Blockchain
#Space
#Robotics

Trending Today